Summary

for people ages 18 years and up (full criteria)
at La Jolla, California and other locations
study started
estimated completion:
Frederick E. Millard

Description

Summary

The primary focus of this study is to see if looking at tumor biomarkers using a program called coexpression extrapolation or "COXEN" may predict a patient's response to chemotherapy before surgery.

Official Title

A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer

Details

The COXEN program will not select a patient's therapy, but the type of chemotherapy that he/she will receive will be randomly decided. The patient's response to chemotherapy will be used to test the usefulness of the COXEN program, which is the main goal of this trial. Other potential tests to predict a patient's response to chemotherapy will also be evaluated. In this study, the patient may receive the treatment in Arm 1 (gemcitabine and cisplatin) or the treatment in Arm 2 [methotrexate, vinblastine, doxorubicin, cisplatin, and filgrastim (or pegfilgrastim)]. There will be about 184 people taking part in this study (92 in each arm).

Keywords

Bladder Cancer Neoadjuvant Chemotherapy Coexpression Extrapolation COXEN S1314 SWOG Urinary Bladder Neoplasms Gemcitabine Liposomal doxorubicin Cisplatin Doxorubicin Methotrexate Vinblastine Lenograstim Filgrastim Gemcitabine & Cisplatin Dose Dense MVAC

Eligibility

You can join if…

Open to people ages 18 years and up

  • Histologically proven bladder cancer (pure small cell carcinoma, pure adenocarcinoma,and pure squamous cell carcinoma histologies are excluded).
  • Stage cT2-T4a N0 M0 disease.
  • Documented muscle invasive disease with at least one of the following: disease measuring at least 10 mm on cross-sectional imaging OR the presence of tumor-associated hydronephrosis.
  • Staging scans with abdominal/pelvic CT or MRI scan and CT scan or x-ray of the chest within 56 days prior to registration. If alkaline phosphatase is above the treating institution's upper limit of normal (ULN), presence of suspicious bone pain, or if other clinical suspicion, a whole body bone scan is required within 56 days prior to registration.
  • Performance status = 0 or 1
  • 18 years of age or older
  • Must have tumor tissue from transurethral resection of the bladder tumor (TURBT)available for submission that is sufficient for COXEN testing and must agree to submission of 20 (10 micron) slides plus 2 (5 micron) slides from the start and end of the 20 slides for a total of 22 unstained slides.
  • Must agree to collection of tissue (if residual disease is present), urine, and whole blood.
  • Must agree to participate in the translational medicine studies outlined in the protocol

You CAN'T join if...

  • Prior systemic cytotoxic chemotherapy or systemic anthracycline
  • Peripheral neuropathy >/= Grade 2
  • Class III/IV heart failure or known left ventricular ejection fraction (LVEF) < 50%
  • Clinically relevant hearing impairment > Grade 2
  • Renal function, calculated creatinine clearance < 60 mL/min
  • Hepatic function, total bilirubin > 1.5 x institutional upper limit of normal (IULN)(or > 2.5 x IULN with Gilbert's disease); AST & ALT > 2 X IULN
  • Hematologic function, absolute neutrophil count (ANC) < 1,500/mcL, hemoglobin < 9 g/dL, and platelets < 100,000/mcL
  • Hypersensitivity to cisplatin, gemcitabine, doxorubicin, vinblastine, methotrexate, or filgrastim/pegfilgrastim
  • Incidence of or uncontrolled medical illness (e.g. active cardiac symptoms, active systemic infection, etc.)
  • Pregnant or nursing females
  • No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated Stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for five years. However,patients with localized prostate cancer who are being followed by an active surveillance program are eligible.

Locations

  • UC San Diego Moores Cancer Center accepting new patients
    La Jolla California 92093 United States
  • USC Norris Oncology/Hematology-Newport Beach accepting new patients
    Newport Beach California 92663 United States
  • Loma Linda University Medical Center accepting new patients
    Loma Linda California 92354 United States
  • City of Hope Comprehensive Cancer Center accepting new patients
    Duarte California 91010 United States
  • Los Angeles County-USC Medical Center accepting new patients
    Los Angeles California 90033 United States
  • USC / Norris Comprehensive Cancer Center accepting new patients
    Los Angeles California 90033 United States
  • City of Hope South Pasadena accepting new patients
    South Pasadena California 91030 United States
  • Cedars Sinai Medical Center currently not accepting new patients, but might later
    Los Angeles California 90048 United States
  • City of Hope Antelope Valley accepting new patients
    Lancaster California 93534 United States
  • Yuma Cancer Center accepting new patients
    Yuma Arizona 85364 United States
  • AIS Cancer Center at San Joaquin Community Hospital accepting new patients
    Bakersfield California 93301 United States
  • Cancer and Blood Specialists-Henderson accepting new patients
    Henderson Nevada 89052 United States
  • Comprehensive Cancer Centers of Nevada - Henderson accepting new patients
    Henderson Nevada 89052 United States
  • Las Vegas Cancer Center-Henderson accepting new patients
    Henderson Nevada 89052 United States
  • HealthCare Partners Medical Group Oncology/Hematology-San Martin accepting new patients
    Las Vegas Nevada 89113 United States
  • Las Vegas Cancer Center-Medical Center accepting new patients
    Las Vegas Nevada 89148-2405 United States
  • 21st Century Oncology - Fort Apache accepting new patients
    Las Vegas Nevada 89148 United States
  • Comprehensive Cancer Centers of Nevada accepting new patients
    Las Vegas Nevada 89148 United States
  • Nevada Cancer Specialists-Fort Apache accepting new patients
    Las Vegas Nevada 89148 United States
  • 21st Century Oncology - Henderson accepting new patients
    Henderson Nevada 89074 United States
  • Comprehensive Cancer Centers of Nevada-Southeast Henderson accepting new patients
    Henderson Nevada 89074 United States
  • PCR Oncology accepting new patients
    Pismo Beach California 93449 United States
  • Radiation Oncology Centers of Nevada Southeast accepting new patients
    Las Vegas Nevada 89119 United States
  • Comprehensive Cancer Centers of Nevada-Summerlin accepting new patients
    Las Vegas Nevada 89144 United States
  • Summerlin Hospital Medical Center accepting new patients
    Las Vegas Nevada 89144 United States
  • University Medical Center of Southern Nevada accepting new patients
    Las Vegas Nevada 89102 United States
  • 21st Century Oncology accepting new patients
    Las Vegas Nevada 89109 United States
  • HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway accepting new patients
    Las Vegas Nevada 89109 United States
  • Comprehensive Cancer Centers of Nevada - Central Valley accepting new patients
    Las Vegas Nevada 89169 United States
  • University Cancer Center accepting new patients
    Las Vegas Nevada 89169 United States
  • Cancer Therapy and Integrative Medicine accepting new patients
    Las Vegas Nevada 89121 United States
  • Ann M Wierman MD LTD accepting new patients
    Las Vegas Nevada 89128 United States
  • Cancer and Blood Specialists-Tenaya accepting new patients
    Las Vegas Nevada 89128 United States
  • Comprehensive Cancer Centers of Nevada - Northwest accepting new patients
    Las Vegas Nevada 89128 United States
  • HealthCare Partners Medical Group Oncology/Hematology-Tenaya accepting new patients
    Las Vegas Nevada 89128 United States
  • Cancer and Blood Specialists-Shadow accepting new patients
    Las Vegas Nevada 89106 United States
  • Nevada Cancer Research Foundation CCOP accepting new patients
    Las Vegas Nevada 89106 United States
  • Radiation Oncology Centers of Nevada Central accepting new patients
    Las Vegas Nevada 89106 United States
  • 21st Century Oncology - Vegas Tenaya accepting new patients
    Las Vegas Nevada 89182 United States
  • HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills accepting new patients
    Las Vegas Nevada 89149 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Southwest Oncology Group
ID
NCT02177695
Phase
Phase 2
Lead Scientist
Frederick E. Millard
Study Type
Interventional
Last Updated
July 13, 2018